Investing.com - Verona Pharma (NASDAQ:VRNA) ADR reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Verona Pharma ADR announced earnings per share of $-0.05 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.5522 on revenue of $0.00.
Verona Pharma ADR shares are down 41.96% from the beginning of the year, still down 49.35% from its 52 week high of $7.70 set on June 10, 2021. They are under-performing the Nasdaq which is down 19.87% from the start of the year.
Verona Pharma ADR follows other major Healthcare sector earnings this month
Verona Pharma ADR's report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar